# Bionano Genomics, Inc.: filings

BNGO · Nasdaq · CIK 1411690 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bngo.md) · [Financials](/companies/bngo/financials.md) · [Filings](/companies/bngo/filings.md) · [Insiders](/companies/bngo/insiders.md)

## Reports and events: 184 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 185, 8-K 119, 3 36, CORRESP 28, 10-Q 24, DEFA14A 21, UPLOAD 16, 424B5 15, EFFECT 13, D 12, S-8 12, DEF 14A 11, S-3 9, SC 13G/A 9, 10-K 8, 424B3 8, S-1/A 8, SCHEDULE 13G 8, 4/A 7, SC 13G 7, SCHEDULE 13G/A 7, CT ORDER 6, PRE 14A 6, S-1 6, 424B4 4, 8-K/A 4, ARS 4, DRS 3, POS EX 3, S-1MEF 3, S-3/A 3, 25-NSE 2, CERT 2, SC 13D 2, SC 13D/A 2, 3/A 1, 5 1, 8-A12B 1, 8-A12B/A 1, DEFR14A 1, DRS/A 1, DRSLTR 1, POSASR 1, PRER14A 1, S-3ASR 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 17:13 ET | [S-1](/filings/0001193125-26-434439.md) | Registration statement | 0001193125-26-434439 |
| 2026-09-14 | 08:30 ET | [8-K](/filings/0001411690-26-000046.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001411690-26-000046 |
| 2026-08-10 | 16:10 ET | [10-Q](/filings/0001411690-26-000044.md) | Quarterly report, period 2026-06-30 | 0001411690-26-000044 |
| 2026-08-10 | 16:05 ET | [8-K](/filings/0001411690-26-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-26-000043 |
| 2026-06-24 | 08:30 ET | [8-K](/filings/0001411690-26-000040.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001411690-26-000040 |
| 2026-06-05 | 16:00 ET | [8-K](/filings/0001411690-26-000036.md) | 5.02 Departure or appointment of officers or directors | 0001411690-26-000036 |
| 2026-05-28 | 08:00 ET | [8-K](/filings/0001411690-26-000033.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001411690-26-000033 |
| 2026-05-14 | 16:29 ET | [8-K](/filings/0001411690-26-000030.md) | 5.07 Shareholder vote results | 0001411690-26-000030 |
| 2026-05-13 | 16:09 ET | [10-Q](/filings/0001411690-26-000028.md) | Quarterly report, period 2026-03-31 | 0001411690-26-000028 |
| 2026-05-13 | 16:03 ET | [8-K](/filings/0001411690-26-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-26-000027 |
| 2026-05-06 | 16:30 ET | [8-K](/filings/0001411690-26-000019.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001411690-26-000019 |
| 2026-04-02 | 16:02 ET | [DEF 14A](/filings/0001411690-26-000014.md) | Proxy statement, period 2026-04-01 | 0001411690-26-000014 |
| 2026-03-23 | 16:08 ET | [10-K](/filings/0001411690-26-000007.md) | Annual report, period 2025-12-31 | 0001411690-26-000007 |
| 2026-03-23 | 16:04 ET | [8-K](/filings/0001411690-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-26-000006 |
| 2026-01-12 | 08:15 ET | [8-K](/filings/0001140361-26-000904.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-000904 |
| 2025-11-13 | 16:09 ET | [10-Q](/filings/0001411690-25-000093.md) | Quarterly report, period 2025-09-30 | 0001411690-25-000093 |
| 2025-11-13 | 16:04 ET | [8-K](/filings/0001411690-25-000092.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-25-000092 |
| 2025-09-18 | 18:02 ET | [8-K](/filings/0001140361-25-035286.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-035286 |
| 2025-09-11 | 11:26 ET | [S-1](/filings/0001140361-25-034651.md) | Registration statement | 0001140361-25-034651 |
| 2025-08-14 | 16:13 ET | [10-Q](/filings/0001411690-25-000083.md) | Quarterly report, period 2025-06-30 | 0001411690-25-000083 |
| 2025-08-14 | 16:04 ET | [8-K](/filings/0001411690-25-000082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-25-000082 |
| 2025-06-18 | 17:15 ET | [8-K/A](/filings/0001411690-25-000077.md) | 5.07 Shareholder vote results | 0001411690-25-000077 |
| 2025-06-13 | 16:24 ET | [8-K](/filings/0001411690-25-000073.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001411690-25-000073 |
| 2025-05-14 | 16:11 ET | [10-Q](/filings/0001411690-25-000046.md) | Quarterly report, period 2025-03-31 | 0001411690-25-000046 |
| 2025-05-14 | 16:09 ET | [8-K](/filings/0001411690-25-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-25-000045 |
| 2025-04-28 | 16:15 ET | [DEF 14A](/filings/0001140361-25-016025.md) | Proxy statement, period 2025-06-11 | 0001140361-25-016025 |
| 2025-03-31 | 16:15 ET | [10-K](/filings/0001411690-25-000037.md) | Annual report, period 2024-12-31 | 0001411690-25-000037 |
| 2025-03-31 | 16:03 ET | [8-K](/filings/0001411690-25-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-25-000036 |
| 2025-02-21 | 16:20 ET | [8-K](/filings/0001140361-25-005427.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-005427 |
| 2025-02-10 | 17:16 ET | [8-K](/filings/0001140361-25-003762.md) | 1.02 Termination of a material agreement | 0001140361-25-003762 |
| 2025-01-27 | 16:05 ET | [8-K](/filings/0001411690-25-000008.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001411690-25-000008 |
| 2025-01-16 | 16:36 ET | [8-K](/filings/0001411690-25-000005.md) | 5.07 Shareholder vote results | 0001411690-25-000005 |
| 2025-01-13 | 16:11 ET | [8-K](/filings/0001411690-25-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-25-000003 |
| 2025-01-06 | 07:10 ET | [8-K](/filings/0001140361-25-000296.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-000296 |
| 2025-01-03 | 08:30 ET | [8-K](/filings/0001140361-25-000132.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000132 |
| 2024-12-05 | 17:00 ET | [DEF 14A](/filings/0001140361-24-048499.md) | Proxy statement, period 2025-01-15 | 0001140361-24-048499 |
| 2024-12-02 | 16:54 ET | [8-K](/filings/0001411690-24-000066.md) | 5.07 Shareholder vote results | 0001411690-24-000066 |
| 2024-11-14 | 16:01 ET | [10-Q](/filings/0001411690-24-000063.md) | Quarterly report, period 2024-09-30 | 0001411690-24-000063 |
| 2024-11-13 | 16:03 ET | [8-K](/filings/0001411690-24-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-24-000060 |
| 2024-10-31 | 08:50 ET | [8-K](/filings/0001140361-24-044715.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-044715 |
| 2024-10-10 | 08:10 ET | [8-K](/filings/0001140361-24-043244.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-043244 |
| 2024-09-09 | 08:00 ET | [8-K](/filings/0001140361-24-040508.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-040508 |
| 2024-08-21 | 16:59 ET | [DEF 14A](/filings/0001140361-24-038087.md) | Proxy statement, period 2024-10-02 | 0001140361-24-038087 |
| 2024-08-07 | 16:59 ET | [10-Q](/filings/0001411690-24-000049.md) | Quarterly report, period 2024-06-30 | 0001411690-24-000049 |
| 2024-08-07 | 16:14 ET | [8-K](/filings/0001411690-24-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-24-000046 |
| 2024-07-18 | 16:17 ET | [8-K](/filings/0001411690-24-000044.md) | 3.01 Delisting notice | 0001411690-24-000044 |
| 2024-07-08 | 06:16 ET | [8-K](/filings/0001140361-24-032559.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-032559 |
| 2024-06-21 | 16:01 ET | [8-K](/filings/0001411690-24-000040.md) | 5.07 Shareholder vote results | 0001411690-24-000040 |
| 2024-05-28 | 08:15 ET | [8-K](/filings/0001140361-24-027553.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-027553 |
| 2024-05-08 | 16:09 ET | [10-Q](/filings/0001411690-24-000021.md) | Quarterly report, period 2024-03-31 | 0001411690-24-000021 |

Page 1 of 4. [Older](/companies/bngo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:14 ET. No prices; not investment advice.